| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | Jan 18, 2024 | AN2 Therapeutics, Inc. | 10% Owner | Sell | 17.5 | -100,000 | -4.04% | ✗ | $2M |
| Nov 14, 2023 | Nov 16, 2023 | AN2 Therapeutics, Inc. | 10% Owner | Sell | 55.0 | -1,810 | -0.07% | ✓ | $29.2K |
| Sep 29, 2023 | Oct 3, 2023 | AN2 Therapeutics, Inc. | 10% Owner | Sell | 32.5 | -104,773 | -4.06% | ✓ | $1.7M |
| Sep 27, 2023 | Sep 29, 2023 | AN2 Therapeutics, Inc. | 10% Owner | Sell | 48.8 | -9,357 | -0.36% | ✓ | $150.7K |
| Sep 13, 2023 | Sep 15, 2023 | AN2 Therapeutics, Inc. | 10% Owner | Sell | 58.8 | -400 | -0.02% | ✓ | $6.4K |
| Sep 6, 2023 | Sep 8, 2023 | AN2 Therapeutics, Inc. | 10% Owner | Sell | 48.8 | -7,140 | -0.27% | ✓ | $114.5K |
| Aug 23, 2023 | Aug 25, 2023 | AN2 Therapeutics, Inc. | 10% Owner | Sell | 52.5 | -400 | -0.02% | ✗ | $6.4K |
| Mar 29, 2022 | Jun 24, 2022 | AN2 Therapeutics, Inc. | 10% Owner | Buy | 95.0 | +166,666 | 8.15% | ✗ | $2.5M |
| Mar 29, 2022 | Mar 31, 2022 | AN2 Therapeutics, Inc. | 10% Owner | Buy | 95.0 | +166,666 | 8.15% | ✗ | $2.5M |